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COMPARISON OF OSTEOARTHRITIS AND NORMAL HIP CARTILAGE
TRANSCRIPTOMES USING RNA-SEQ REVEALS NEW CANDIDATE
GENE TARGETS AND ASSOCIATED PATHWAYS
Y. Xu, M.J. Barter, D.C. Swan, K.S. Rankin, A.D. Rowan, M. Santibanez-
Koref, J. Loughlin, D.A. Young. Newcastle Univ., Newcastle upon Tyne,
United Kingdom
Purpose: Osteoarthritis (OA) is the most prevalent joint disease, leading
to progressive degradation of the articular cartilage. To investigate
precise molecular changes occurring in the cartilage during disease
development, we used RNA sequencing (RNA-seq) to compare the
transcriptome of OA and normal hip cartilage. Based on Next Genera-
tion DNA sequencing technology, RNA-seq is not only able to determine
gene expression levels genome-wide but can also identify alternative
splicing events, new classes of RNA and single nucleotide poly-
morphisms (SNPs). Here we have focused on expression analysis.
Methods: Total RNA was isolated from human articular cartilage
samples obtained from consented patients undergoing joint replace-
ment surgery due to either end-stage hip OA or neck of femur fracture
(NOF). 78-base paired-end sequencing was performed on an Illumina
Genome Analyzer IIx according to the manufacturer's protocol.
Sequencing reads were ﬁltered to trim low quality ends before aligning
them to known human genome transcript sequences using Novocraft
Novoalign. Bioconductor package cqn was used to normalize read
counts and minimize bias due to gene length and GC content. Samples
were clustered according to their expression proﬁles to check quality of
RNA samples and differentially expressed genes were identiﬁed using
Bioconductor package edgeR. Function and pathway analyses were
performed with the Ingenuity Pathway Analysis package. The results
were compared and veriﬁed using the results from whole-genome
microarray experiments.
Results: On average, 54 million 78-base pair-end reads were produced
for RNAs from each OA (n¼10) and NOF (n¼6) cartilage sample. At least
26% of transcripts in each sample had a coverage depth 0.9. Clear
separation of OA and NOF samples in the hierarchical clustering result
indicated the reliability of the expression proﬁles. In total, 1434 genes
(P-values0.01, fold change -2 or 2) were identiﬁed as differentially
expressed. Changes in the expression of these genes signiﬁcantly
correlated with equivalent changes in traditional microarray hybrid-
ization experiments (r ¼ 0.84) but revealed novel associations with
a number of canonical pathways, such as IL-6 (P-value¼0.00036),
HMGB1 (P-value¼0.001), toll-like receptor (P-value¼0.013) and BMP
(P-value¼0.044) signaling.
Conclusions: This is the ﬁrst application of RNA-seq to investigate OA
cartilage. Transcriptomes obtained with this method have excellent
correlation with expression data from a microarray platform but also
show improved sensitivity and the ability to detect a wider range of
expression changes. This has allowed us to identify a number of addi-
tional pathogenic pathways associated with OA. With conﬁrmation of
the quality and reliability of the RNA-seq data, we will proceed to
determine alternative splicing events, novel RNAs and other post-
transcriptional events.
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SUBSTANTIAL ALTERATION OF POST-TRANSCRIPTIONAL GENE
CONTROL IN CHONDROCYTES FROM OSTEOARTHRITIC JOINTS
S.R. Tew, B. McDermott, O. Vasieva, P.D. Clegg. Univ. of Liverpool,
Liverpool, United Kingdom
Purpose: Regulation of mRNA decay rates offers cells a means of
controlling not only gene expression levels but also gene responsive-
ness to altered transcriptional input. We have previously shown that
important chondrocyte markers such as SOX9 and COL2A1 can be
controlled post-transcriptionally in chondrocytes if exposed to cell
stresses such as hyperosmolarity. Interestingly, recent evidence shows
that molecules that are known to control mRNA decay, such as micro-
RNAs, are regulated during osteoarthritis (OA). In this studywe aimed to
determine, for the ﬁrst time, the effect of OA pathology on the rates of
mRNA decay across the chondrocyte transcriptome.
Methods: Human articular chondrocytes (HAC) were isolated from
normal cartilage (N), macroscopically intact OA tissue (I) or macro-
scopically degenerate OA tissue (D) and used within 24 hours. An
osteochondral sample from each specimen was collected to allow
histological grading. RNA decay was measured using microarrayanalysis of HAC total RNA, which was collected 0, 1, 3 and 5 hours after
treatment of the HAC with the transcription inhibitor actinomycin D.
Transcriptome-wide mRNA half-lives were determined by linear
regression and signiﬁcant differences between the rates observed in
different tissue sources was determined using student's t-test with false
discovery rate testing. Gene ontology investigations were carried out
using Ingenuity Pathway Analysis (IPA).
Results: Initial examination of total mRNA expression levels (using the
time 0 values of the decay curves) demonstrated signiﬁcant differences
in the expression of transcripts between normal and osteoarthritic
cartilage (N vs. I and N vs. D), which in many instances involved regu-
lation of the same genes. Interestingly, we found almost no signiﬁcant
difference in total mRNA expression between chondrocytes isolated
from either intact vs. degenerate OA cartilage (I vs. D). Subsequent
examination of the half-life of mRNA in chondrocytes from these
different tissues also showed greater variation between the normal
chondrocytes and the OA chondrocytes. However, in contrast to total
RNA analysis, we detected high numbers of signiﬁcantly regulated genes
in comparisonsbetweeneverygroup. (Nvs. I¼592,Nvs.D¼417, I vs.D¼
361). Despite demonstrating altered post-transcriptional control, most
of these genes did not display overall regulation at their transcript level.
Examination of the post-transcriptionally regulated genes using IPA
indicated that pathways such as NFkB and JAK/STAT were affected
through altered post-transcriptional control in OA, as well as pathways
controlling cell cycle, apoptosis and extracellular matrix synthesis.
Conclusions: The surprising ﬁnd of this study is the large number of
transcripts whose decay rates are altered in osteoarthritis; greater than
the number of genes whose overall expression was regulated. These
changes, despite the unchanged steady state expression of these genes
in health and disease, provides evidence that OA substantially affects
the regulatory dynamics that underpin gene expression levels and
could consequently alter the genes’ response to transcriptional stim-
ulus. This might play an important role in the development and
progression of OA pathology.
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INHIBITION OF WNT/B-CATENIN PATHWAY BY SCLEROSTIN
PROMOTES CARTILAGE MAINTENANCE
W. Bouaziz, T. Funk-Brentano, H. Lin, E. Hay, M. Cohen-Solal. INSERM606,
Paris, France
Purpose: Cartilage homeostasis is regulated by several mechanisms
that inﬂuence both anabolic and catabolic balance. Among them, the
local activation of Wnt pathways plays a major role in chondrocyte
activity which might be regulated by Wnt inhibitors. Sclerostin, a Wnt
inhibitor mainly produced by osteocytes and hypertrophic chon-
drocytes, might participate to the crosstalk between bone and cartilage.
Therefore, the aim of this study is to determine the effect of Sclerostin in
chondrocyte function.
Methods: Primary murine chondrocytes, isolated from long bone
epiphysis of 6 day-old mice, were cultured with or without Wnt3a
conditionedmedia (Wnt3aCM) and in the presence or absence ofmouse
recombinant Sclerostin. Proteoglycan release induced by Wnt was
quantiﬁed in the supernatant of chondrocytes by a colorimetric assay.
Activation and inhibition of Wnt pathway was shown by the trans-
location of b-catenin (IF, TOP-GAL activity). BrdU and Tunel assays were
performed to test the effect of Wnt and Sclerostin on cell proliferation
and apoptosis. Chondrocyte differentiation induced by Sclerostin was
investigated by RT-qPCR through the relative expression of type II and X
collagen, Sox9, aggrecan, MMP-3, MMP-13 ADAMTS-4 & 5 genes.
Results: Wnt3aCM reduced proteoglycan release in a dose-dependent
manner and was rescued by Sclerostin (20ng/ml). This dose was chosen
for the following experiments. Wnt inhibited the gene expression of
collagen type II (X18-fold), Sox9 (X140 fold) and Aggrecan (X90-fold) and
increases the gene expression of metalloproteinases such as Adamts-4
(X5-fold), Adamts-5 (X5.5-fold), MMP3 (X7-fold) and MMP13 (X6.6-
fold). Sclerostin was able to inhibit the nuclear translocation of b-catenin
induced by Wnt, but failed to exert any effect in the proliferation or
apoptosis in primary chondrocytes regardless of Wnt. However, Wnt3a
increased the gene expression of collagen type X (X3-fold) which was
abolished by Sclerostin (X1.6-fold). Sclerostin signiﬁcantly inhibited the
Wnt-induced increase of catabolic genes (X1.7-fold Adamts-4, X1.6-fold
Adamts-5, X3.4-fold MMP3 and X4-fold MMP13) and rescues partially
the expression of anabolic genes (X5- fold collagen type II, X6-fold Sox-9
and X11-fold Aggrecan). In addition, Wnt3a induced the expression of
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further observed an enhanced expression of Sclerostin in osteoarthritic
cartilage compared to cartilage of control mice.
Conclusions:We here show that Wnt3a increases the catabolic activity
and inhibits the anabolic activity in murine chondrocytes. Sclerostin
alleviates the expression of catabolic genes induced byWnt and rescued
proteoglycan production. Moreover, Sclerostin promotes the cartilage
maintenance through the inhibition of chondrocyte hypertrophy.
Finally, the expression of Sclerostin expression in osteoarthritic mice
suggests that Sclerostin might be involved in the pathophysiology in
cartilage damage and might constitute a target for the prevention of
osteoarthritis.
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ROLE OF STROMAL CELL-DERIVED FACTOR-1 ALPHA ON
ENDOCHONDRAL OSSIFICATION
G. Kim 1,2, S. Han 1,2, Y. Jung 2, S. Usmani 3,4, V. Ulici 3,4,
F. Beier 3,4. 1Daegu fatima Hosp., Daegu, Republic of Korea; 2 Lab. for
arthritis and bone biology, Fatima research Inst., Daegu, Republic of
Korea; 3Dept. of Physiology and Pharmacology, Univ. of Western
Ontario, London, ON, Canada; 4CIHR Group in Skeletal Dev. and
Remodeling, London, ON, Canada
Purpose: The main cellular events of articular chondrocytes during
osteoarthritis are a loss of the traits as permanent cartilage, and
a transition to hypertrophic chondrocytes responding to excessive
stress. Aberrant endochondral ossiﬁcation in the articular cartilage,
such as chondrocyte proliferation, differentiation and apoptosis, are
thought to play an important role in the development of osteoarthritis.
The research about molecular mechanisms controlling the endochon-
dral ossiﬁcation in the growth plate of bone thus can give us an
important clue to understand the pathogenesis of osteoarthritis. Several
lines of evidences suggest that the stromal cell-derived factor-1 alpha
(SDF-1a) has been implicated in osteoarthritis, but their exact mecha-
nisms still remains unclear. In this study, we investigated the roles of
SDF-1a on the endochondral ossiﬁcation.
Methods: Primary chondrocytes and tibial explants from embryonic 15.5
day-oldmicewereculturedwithPBSvehicleor recombinantmouseSDF-1a.
Total RNA was isolated from primary cell cultures using a Qiagen RNeasy
Mini Kit. Real-time PCR analysis was performed using Applied Biosystems
7900 HT Real-Time PCR System and TaqMan Gene Expression Assays for
Sox9, Col2a1, Acan, MMP13, Col10a1, Runx2. Organ culture tissues were
stained with safranin O/fast green and alcian blue/alizarin red, and the
immunohistochemistry was also performed on tissue sections with anti-
Caspase3, anti-MMP13, anti-Runx2, anti-COL10, anti-proliferating chon-
drocyte nuclear antigen (PCNA) and anti-SOX9 antibodies
Results:Primarychondrocyte cultures revealed that SDF-1a signiﬁcantly
increased the expression of aggrecan and Col10a1 which is a marker for
chondrocyte proliferation and hypertrophy, respectively (p<0.05). The
master regulator gene of chondrocyte hypertrophy, Runx2, was also up-
regulated in messenger RNA level by SDF-1a (p<0.05). To gain further
insights into the role of SDF-1a on endochondral ossiﬁcation, we
examined the effects of SDF-1a in tibia organ cultures. The length of
tibias, comparedwith the controls, was signiﬁcantly increased in SDF-1a
treatment group (p<0.05). Immunohistochemical staining of organ
cultures agreed with the morphologic ﬁnding; the expression of PCNA,
themarker for chondrocyteproliferationandSox9markedly increased in
chondrocytes of proliferating zone. In addition to proliferation marker,
type 10 collagen, the marker for hypertrophy and Caspase3, were up-
regulated in hypertrophic zone by SDF-1a.
Conclusions: Our ﬁndings reveal that SDF-1a has an effect on chon-
drocyte proliferation, hypertrophy and apoptosis during endochondral
ossiﬁcation through Sox9 and Runx2. SDF-1a thus may represent
a therapeutic target of osteoarthritis.
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NG2/CSPG4 REGULATES AGGRECANASE AND MMP EXPRESSION IN
HUMAN CHONDROCYTES
N.S. Jamil, A. Azfer, H.E. Sarah, D.M. Salter. Univ. of Edinburgh, Edinburgh,
United Kingdom
Purpose: NG2/CSPG4 is a chondroitin sulphate rich transmembrane
proteoglycan. It is expressed by a number of different cell types
including neuronal cells and melanocytes and appears to be involved inregulation of cell migration, spreading, proliferation and death.
Expression in developing and adult cartilage has been recognised for
some time but less is known of its roles in regulating chondrocyte
function. The purpose of the study was to investigate expression and
interactions of NG2/CSPG4 in chondrocytes and establish whether this
molecule is involved in regulation of gene expression of cartilage
speciﬁc molecules and proteases involved in cartilage breakdown.
Methods: Chondrocytes from osteoarthritic human articular cartilage
(OA), C20A4, an immortalised chondrocyte cell line and JJ012, grade II
chondrosarcoma cell line were used. NG2/CSPG4 expression was
investigated by immunoﬂuorescence, western blotting and RT-PCR.
Interactions within the Golgi complex and endoplasmic reticulumwere
assessed by double immunoﬂuorescence. Biochemical interactions
were assessed by immunoprecipitation and mass spectroscopy. Roles in
gene regulation were studied by shRNA knockdown of NG2/CSPG4 in
JJ012 cells and assessment of gene expression by RTPCR.
Results: NG2/CSPG4 was expressed by all cells studied. Western blot-
ting of extracts from OA chondrocytes showed molecular weight forms
of around 400, 270 and 55kD without chondroitinase treatment and
four forms of 270 238, 117 and 55kD following chondroitinase pre-
treatment. NG2/CSPG4 was distributed predominantly at the cell
surface of JJ012 cells. In OA chondrocytes distribution was both as the
cell surface and within the cytoplasm with double
immunoﬂuorescence indicating that NG2 is localised with the Golgi
complex but not the ER. Immunoprecipitation and mass spectrometry
data demonstrated associations between NG2/CSPG4 and both
collagen VI and thrombospondin in OA chondrocytes. Following NG2
knockdown in JJ012 cells there was no difference in expression of
aggrecan, collagen II and SOX-9. In contrast cells in which NG2/CSPG4
had been knocked down showed decreased expression of MPP3 and
ADAMTS-4, a complete loss of ADAMTS-5 and increased expression of
MMP13.
Conclusions: In this study we have identiﬁed expression of multiple
forms of NG2/CSPG4 in human OA chondrocytes and shown association
of this molecule with type VI collagen and thrombospondin. Loss of
NG2/CSPG4 induced changes in expression of aggrecanases and MMPs.
Altered expression or associations of NG2/CSPG4 with extracellular
ligands or intracellular signalling cascades may be important in the
pathogenesis of OA by regulating proteolytic activity or apoptosis
related pathways.
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ACTIVATION OF AMP-ACTIVATED PROTEIN KINASE (AMPK) INHIBITS
CHONDROCYTE CATABOLIC RESPONSE TO PRO-INFLAMMATORY
CYTOKINES AND UP-REGULATES ANTI-OXIDANT GENES VIA PPARg
COACTIVATOR 1a (PGC-1a) AND FORKHEAD BOX O FACTOR 3
(FOXO3A)
X. Zhao 1, R. Terkeltaub 1, M. Lotz 2, R. Liu-Bryan 1. 1VAMC, UCSD, San
Diego, CA, USA; 2 The Scripps Res. Inst., La Jolla, CA, USA
Purpose: AMPK is a super-regulator of cellular energy homeostasis and
metabolism.We have previously reported that AMPK activity is reduced
in human knee OA articular chondrocytes and in cultured primary
normal chondrocytes stimulated with inﬂammatory cytokines IL-1b
and TNFa. AMPK pharmacologic activators suppress chondrocyte
catabolic responses to IL-1b and TNFa by inhibition of NF-kB activation.
In addition, we observed that AMPK activity is promoted by upstream
kinase LKB1 and inhibited by protein phosphatase PP2Ca in articular
chondrocytes. Because PGC-1a (a master regulator of mitochondria
biogenesis) and FOXO3a (a direct transcriptional regulator of PGC-1) are
downstream targets of AMPK that have been shown to mediate anti-
inﬂammatory effect of AMPK and regulate oxidative stress protect
genes, we tested if PGC-1a and FOXO3a mediate AMPK to inhibit
catabolic responses induced by IL-1b and TNFa, and regulate expression
of anti-oxidant genes such as manganese superoxide dismutase
(MnSOD or SOD2), catalase and thioredoxin in articular chondrocytes.
Methods: Expression of PGC-1a or FOXO3a in normal human knee
articular chondrocytes was knocked down via siRNA transfection. These
knockdown chondrocytes were then stimulated with IL-1b (10 ng/ml)
and TNFa (20 ng/ml). Phosphorylation of p65 (Ser536) NF-kB subunit
was examined at 4 hours after stimulation by Western blot analysis.
Pro-catabolic responses including nitric oxide (NO) generation and
expression of MMP-3 assessed by Griess reaction and Western Blot
analysis, respectively, at 18 hours after stimulation. Additionally, mouse
chondrocytes isolated from femoral head cartilages of AMPKa1
